Tarsus Pharmaceuticals Inc. (TARS)
NASDAQ · Healthcare
Tarsus Pharmaceuticals Inc. Shareholder Equity 2020–2025
Tarsus Pharmaceuticals Inc. annual shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Tarsus Pharmaceuticals Inc. shareholder equity as of December 31, 2025: 343.4M, a 52.95% increase year-over-year.
- Tarsus Pharmaceuticals Inc. shareholder equity for 2025 were 343.4M, a 52.95% increase from 2024.
- Tarsus Pharmaceuticals Inc. shareholder equity for 2024 were 224.5M, a 13.98% increase from 2023.
- Tarsus Pharmaceuticals Inc. shareholder equity for 2023 were 197.0M, a 2.12% increase from 2022.
- Tarsus Pharmaceuticals Inc. shareholder equity for 2022 were 192.9M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Tarsus Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $343 |
| 2024 | $225 |
| 2023 | $197 |
| 2022 | $193 |
| 2021 | $167 |
| 2020 | $166 |
Tarsus Pharmaceuticals Inc. Shareholder Equity — FAQ
Tarsus Pharmaceuticals Inc. (TARS) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TARS's shareholder equity history?
The chart and table above show Tarsus Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.